Potentiation of Antitumor CTL Response by GM-CSF Involves a B7-Dependent Mechanism
- 1 June 1997
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 178 (2) , 152-161
- https://doi.org/10.1006/cimm.1997.1130
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Low-dose-melphalan-induced up-regulation of type-1 cytokine expression in the s.c. tumor nodule of MOPC-315 tumor bearers and the role of interferon γ in the therapeutic outcomeCancer Immunology, Immunotherapy, 1995
- Expression of cytokine mRNA in human melanoma tissuesCancer Immunology, Immunotherapy, 1995
- Induction of TH1- and TH2-associated cytokine mRNA in mouse bladder following intravesical growth of the murine bladder tumor MB49 and BCG immunotherapyCancer Immunology, Immunotherapy, 1994
- Transforming growth factor-?-mediated down-regulation of antitumor cytotoxicity of spleen cells from MOPC-315 tumor-bearing mice engaged in tumor eradication following low-dose melphalan therapyCancer Immunology, Immunotherapy, 1994
- Low-dose melphalan-induced shift in the production of a Th2-type cytokine to a Th1-type cytokine in mice bearing a large MOPC-315 tumorCancer Immunology, Immunotherapy, 1994
- GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cellsNature, 1992
- The Pathophysiology of Tumor Necrosis FactorsAnnual Review of Immunology, 1992
- Thymic lymphomas mediate non-MHC-restricted, TNF-dependent lysis of the murine sarcoma WEHI-164Cellular Immunology, 1991
- Recombinant human TNF induces production of granulocyte–monocyte colony-stimulating factorNature, 1986
- Induction of Macrophage Tumoricidal Activity by Granulocyte-Macrophage Colony-Stimulating FactorScience, 1986